TipRanks on MSN
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
Detailed price information for Bionxt Solutions Inc. (BNXT-CN) from The Globe and Mail including charting and trades.
Grenada’s economy continues to navigate elevated global uncertainties well in the aftermath of Hurricane Beryl.
ServiceNow (NYSE: NOW), the AI platform for business transformation, today announced financial results for its third quarter ended September 30, 2025, with subscription revenues of $3,299 million in ...
Macworld on MSN
Apple Watch Series 11 review: The best (but don’t buy it)
Macworld At a glance Expert's Rating Pros ・Looks and feels great ・Superb battery life ・Fast charging Cons ・Feels overpriced next to SE 3 Our Verdict The Apple Watch Series 11 is a truly excellent ...
Entergy Corporation (NYSE: ETR) reported third quarter 2025 earnings per share of $1.53 on an as-reported and an adjusted (non-GAAP) basis.
From an equilibrium standpoint, record corporate profits and free cash flow, particularly as a share of GDP, are the mirror ...
BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery ...
Baron Real Estate Income Fund advanced in Q3 2025, outperforming the MSCI US REIT Index. Top contributors were Welltower Inc., Wynn Resorts, Limited, and Prologis, Inc. Top detractors were American ...
The Estée Lauder Companies Inc. today reported its financial results for the first quarter ended September 30, 2025. "We had a strong start to fiscal 2026 as we execute on our Beauty Reimagined ...
Company narrows guidance range and extends financial outlooks NEW ORLEANS, Oct. 29, 2025 /PRNewswire/ -- Entergy Corporation (NYSE: ETR) reported third quarter 2025 ...
Objective To assess family caregiver burden and associated factors among caregivers of people with mental illness in Eastern Ethiopia. Design Cross-sectional study. Setting Three hospitals in Eastern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results